As of now, studies have revealed that targeting PKM2 can, not only, mediate the biological activity of cancer cells, but also affect the effectiveness of therapies towards cancer, such as, in pancreatic cancer cells. This evidence concerns the gene PKM and pancreatic neoplasm.